Combined hormonal contraception may be protective against neisseria gonorrhoeae infection

Sexually Transmitted Diseases

Volumn 37, Issue 6, 2010, Pages 356-360

  Gursahaney, Priya R ^a   Meyn, Leslie A ^a   Hillier, Sharon L ^a   Sweet, Richard L ^b   Wiesenfeld, Harold C ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Allegheny County Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GONOCOCCAL URETHRITIS; GONORRHEA; HORMONAL CONTRACEPTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GONORRHEA; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MEDROXYPROGESTERONE ACETATE; NEISSERIA GONORRHOEAE; SEXUAL BEHAVIOR; TREATMENT OUTCOME; URETHRITIS; UTERINE CERVICITIS; YOUNG ADULT;

EID: 77953120994     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181d40ff1     Document Type: Article

References (30)

1. McCormack WM, Stumacher RJ, Johnson K, et al. Clinical spectrum of gonococcal infection in women. Lancet 1977; 1:1182-1185.
2. McCormack WM, Reynolds GH; Cooperative Study Group. Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae. JAMA 1982; 247:1292-1294.
3. Lin JL, Donegan SP, Heeren TC, et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998; 178: 1707-1712.
4. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983; 250: 3205-3209.
5. Warner L, Stone KM, Macaluso M, et al. Condom use and risk of gonorrhea and chlamydia: A systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33:36-51.
6. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: The validity of self-reported condom use. Sex Transm Dis 1995; 22:15-21.
7. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial Vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Inf Dis 2003; 36:663-667.
8. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 2001; 185:380-385.
9. Mohllajee AP, Curtis KM, Martins SL, et al. Hormonal contraceptive use and risk of sexually transmitted infections: A systematic review. Contraception 2006; 73:154-165.
10. Louv WC, Austin H, Perlman J, et al. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 1989; 160:396-402.
11. Berger GS, Keith L, Moss W. Prevalence of gonorrhoea among women using various methods of contraception. Br J Vener Dis 1975; 51:307-309.
12. Myer L, Denny L, Wright TC, et al. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174.
13. Lavreys L, Chohan V, Overbaugh J, et al. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 2004; 18:2179-2184.
14. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: Insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002; 100:456-463.
15. Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica 2008; 42:992-998.
16. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
17. Sweet RL, Blankfort-Doyle M, Robbie MO, et al. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986; 255:2062-2064.
18. Britigan BE, Cohen MS, Sparling PF. Gonococcal infection: A model of molecular pathogenesis. N Engl J Med 1985; 312:1683-1694.
19. Kita E, Takahashi S, Yasui K, et al. Effect of estrogen (17 beta-estradiol) on the susceptibility of mice to disseminated gonococcal infection. Infect Immune 1985; 49:238-243.
20. Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect 1998; 74:11-19.
21. Morse SA, Fitzgerald TJ. Effect of progesterone on Neisseria gonorrhoeae. Infect Immune 1974; 10:1370-1377.
22. Salit IE. The differential susceptibility of gonococcal opacity variants to sex hormones. Can J Microbiol 1982; 28:301-306.
23. Moriyama A, Shimoya K, Ogata I, et al. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod 1999; 5:656-661.
24. Ming L, Xiaoling P, Yan L, et al. Purification of antimicrobial factors from human cervical mucus. Hum Reprod 2007; 22: 1810-1815.
25. Wolf DP, Blasco L, Khan MA, et al. Human cervical mucus: Part II. Changes in viscoelasticity during the ovulatory menstrual cycle. Fertil Steril 1977; 28:47-52.
26. Bhattacharyya MN, Jephcott AE. Diagnosis of gonorrhea in women-influence of the contraceptive pill. J Am Vener Dis Assoc 1976; 2:21-24.
27. McKenna WR, Mickelson PA, Sparling PF, et al. Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae. Infect Immune 1988; 56:785-791.
28. Serkin CD, Seifert HS. Iron availability regulates DNA recombination in Neisseria gonorrhoeae. Mol Microbiol 2000; 37: 1075-1086.
29. Klausner JD, Barrett DC, Dithmer D, et al. Risk factors for repeated gonococcal infections: San Francisco, 1990-1992. J Infect Dis 1998; 177:1766-1769.
30. Hubacher D, Raymond ER, Beksinska M, et al. Hormonal contraception and the risks of STI acquisition: Results of a feasibility study to plan a future randomized trial. Contraception 2008; 77:366-370.